Last reviewed · How we verify

NCT04083105

Nitrous Oxide Prior to Intranasal Midazolam for Moderate Dental Sedation in Pediatric Patients

Status unknown Phase 4 Last updated 10 September 2019
What this trial tests

Phase 4 trial testing Nitrous Oxide in Dental Anxiety in 150 participants. Status unknown.

Timeline
12 July 2019
Primary endpoint
11 July 2021
11 July 2021

Quick facts

Lead sponsorChildren's Hospital Colorado
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment150
Start date12 July 2019
Primary completion11 July 2021
Estimated completion11 July 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital Colorado

Who can join

Adults 3 to 8, any sex, with Dental Anxiety or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the effectiveness of nitrous oxide/oxygen administration in reducing the discomfort of intranasal midazolam administration for moderate sedation for dental procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Nitrous Oxide

Trials testing the same drug.

Other recruiting trials for Dental Anxiety

Currently open trials in the same condition.

Other Children's Hospital Colorado trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04083105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing